What Is the Efficacy of Sotrovimab in Reducing Disease Progression and Death in People with COVID-19 during the Omicron Era? Answers from a Real-Life Study

(1) Introduction: Since May 2021, sotrovimab has been available in Italy for early treatment of SARS-CoV-2 infection and to prevent disease progression. However, some in vitro studies have questioned its efficacy on Omicron variants. Therefore, we aim to further investigate the efficacy of sotrovima...

Descripción completa

Detalles Bibliográficos
Autores principales: De Vito, Andrea, Colpani, Agnese, Poliseno, Mariacristina, Diella, Lucia, Ieva, Francesco Rosario Paolo, Belati, Alessandra, Papale, Roberto, Babudieri, Sergio, De Santis, Laura, Saracino, Annalisa, Lo Caputo, Sergio, Madeddu, Giordano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458484/
https://www.ncbi.nlm.nih.gov/pubmed/37632099
http://dx.doi.org/10.3390/v15081757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458484/
https://www.ncbi.nlm.nih.gov/pubmed/37632099
http://dx.doi.org/10.3390/v15081757

Ejemplares similares